170 related articles for article (PubMed ID: 35440604)
1. xCT contributes to colorectal cancer tumorigenesis through upregulation of the MELK oncogene and activation of the AKT/mTOR cascade.
Tang B; Zhu J; Liu F; Ding J; Wang Y; Fang S; Zheng L; Qiu R; Chen M; Shu G; Xu M; Lu C; Zhao Z; Yang Y; Ji J
Cell Death Dis; 2022 Apr; 13(4):373. PubMed ID: 35440604
[TBL] [Abstract][Full Text] [Related]
2. MELK promotes Endometrial carcinoma progression via activating mTOR signaling pathway.
Xu Q; Ge Q; Zhou Y; Yang B; Yang Q; Jiang S; Jiang R; Ai Z; Zhang Z; Teng Y
EBioMedicine; 2020 Jan; 51():102609. PubMed ID: 31915116
[TBL] [Abstract][Full Text] [Related]
3. Atractylenolide I inhibits colorectal cancer cell proliferation by affecting metabolism and stemness via AKT/mTOR signaling.
Wang K; Huang W; Sang X; Wu X; Shan Q; Tang D; Xu X; Cao G
Phytomedicine; 2020 Mar; 68():153191. PubMed ID: 32135457
[TBL] [Abstract][Full Text] [Related]
4. Pyrroline-5-Carboxylate Reductase-2 Promotes Colorectal Cancer Progression via Activating PI3K/AKT/mTOR Pathway.
Yin F; Huang X; Xuan Y
Dis Markers; 2021; 2021():9950663. PubMed ID: 34512817
[TBL] [Abstract][Full Text] [Related]
5. ARHGAP9 inhibits colorectal cancer cell proliferation, invasion and EMT via targeting PI3K/AKT/mTOR signaling pathway.
Sun J; Zhao X; Jiang H; Yang T; Li D; Yang X; Jia A; Ma Y; Qian Z
Tissue Cell; 2022 Aug; 77():101817. PubMed ID: 35679685
[TBL] [Abstract][Full Text] [Related]
6. The up-regulated lncRNA DLX6-AS1 in colorectal cancer promotes cell proliferation, invasion and migration via modulating PI3K/AKT/mTOR pathway.
Zhang JJ; Xu WR; Chen B; Wang YY; Yang N; Wang LJ; Zhang YL
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8321-8331. PubMed ID: 31646562
[TBL] [Abstract][Full Text] [Related]
7. CTSG Suppresses Colorectal Cancer Progression through Negative Regulation of Akt/mTOR/Bcl2 Signaling Pathway.
Chan S; Wang X; Wang Z; Du Y; Zuo X; Chen J; Sun R; Zhang Q; Lin L; Yang Y; Yu Z; Zhao H; Zhang H; Chen W
Int J Biol Sci; 2023; 19(7):2220-2233. PubMed ID: 37151875
[TBL] [Abstract][Full Text] [Related]
8. mTOR-dependent upregulation of xCT blocks melanin synthesis and promotes tumorigenesis.
Li C; Chen H; Lan Z; He S; Chen R; Wang F; Liu Z; Li K; Cheng L; Liu Y; Sun K; Wan X; Chen X; Peng H; Li L; Zhang Y; Jing Y; Huang M; Wang Y; Wang Y; Jiang J; Zha X; Chen L; Zhang H
Cell Death Differ; 2019 Oct; 26(10):2015-2028. PubMed ID: 30760873
[TBL] [Abstract][Full Text] [Related]
9. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J
J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405
[TBL] [Abstract][Full Text] [Related]
10. Activation of the PI3K/Akt/mTOR/p70S6K pathway is involved in S100A4-induced viability and migration in colorectal cancer cells.
Wang H; Duan L; Zou Z; Li H; Yuan S; Chen X; Zhang Y; Li X; Sun H; Zha H; Zhang Y; Zhou L
Int J Med Sci; 2014; 11(8):841-9. PubMed ID: 24936148
[TBL] [Abstract][Full Text] [Related]
11. ERK and AKT signaling cooperate to translationally regulate survivin expression for metastatic progression of colorectal cancer.
Ye Q; Cai W; Zheng Y; Evers BM; She QB
Oncogene; 2014 Apr; 33(14):1828-39. PubMed ID: 23624914
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-7 inhibits colorectal cancer cell proliferation, migration and invasion via TYRO3 and phosphoinositide 3-kinase/protein B kinase/mammalian target of rapamycin pathway suppression.
Qin A; Qian W
Int J Mol Med; 2018 Nov; 42(5):2503-2514. PubMed ID: 30226533
[TBL] [Abstract][Full Text] [Related]
13. α-enolase promotes tumorigenesis and metastasis via regulating AMPK/mTOR pathway in colorectal cancer.
Zhan P; Zhao S; Yan H; Yin C; Xiao Y; Wang Y; Ni R; Chen W; Wei G; Zhang P
Mol Carcinog; 2017 May; 56(5):1427-1437. PubMed ID: 27996156
[TBL] [Abstract][Full Text] [Related]
14. Tumor suppressive effect of scavenger receptor class A member 5 overexpression in colorectal cancer by regulating PI3K/AKT/mTOR pathway.
Li Y; Peng F; Tan X; Wang J; Xu Y
Genes Genomics; 2021 Oct; 43(10):1189-1198. PubMed ID: 34417976
[TBL] [Abstract][Full Text] [Related]
15. HOTAIR/miR-326/FUT6 axis facilitates colorectal cancer progression through regulating fucosylation of CD44 via PI3K/AKT/mTOR pathway.
Pan S; Liu Y; Liu Q; Xiao Y; Liu B; Ren X; Qi X; Zhou H; Zeng C; Jia L
Biochim Biophys Acta Mol Cell Res; 2019 May; 1866(5):750-760. PubMed ID: 30742932
[TBL] [Abstract][Full Text] [Related]
16. SP1-induced lncRNA TINCR overexpression contributes to colorectal cancer progression by sponging miR-7-5p.
Yu S; Wang D; Shao Y; Zhang T; Xie H; Jiang X; Deng Q; Jiao Y; Yang J; Cai C; Sun L
Aging (Albany NY); 2019 Mar; 11(5):1389-1403. PubMed ID: 30853664
[TBL] [Abstract][Full Text] [Related]
17. CAFs-secreted exosomal cricN4BP2L2 promoted colorectal cancer stemness and chemoresistance by interacting with EIF4A3.
Qu Z; Yang KD; Luo BH; Zhang F
Exp Cell Res; 2022 Sep; 418(2):113266. PubMed ID: 35752345
[TBL] [Abstract][Full Text] [Related]
18. MELK Accelerates the Progression of Colorectal Cancer via Activating the FAK/Src Pathway.
Liu G; Zhan W; Guo W; Hu F; Qin J; Li R; Liao X
Biochem Genet; 2020 Oct; 58(5):771-782. PubMed ID: 32472210
[TBL] [Abstract][Full Text] [Related]
19. CSRP2 suppresses colorectal cancer progression
Chen L; Long X; Duan S; Liu X; Chen J; Lan J; Liu X; Huang W; Geng J; Zhou J
Theranostics; 2020; 10(24):11063-11079. PubMed ID: 33042270
[TBL] [Abstract][Full Text] [Related]
20. Dihydroartemisinin inhibited stem cell-like properties and enhanced oxaliplatin sensitivity of colorectal cancer via AKT/mTOR signaling.
Wang Y; Yang Z; Zhu W; Chen Y; He X; Li J; Han Z; Yang Y; Liu W; Zhang K
Drug Dev Res; 2023 Aug; 84(5):988-998. PubMed ID: 37132439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]